Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Declining Incidence of Keratinocyte Carcinoma in Organ Transplant Recipients.

Menzies S, 'Leary EO, Callaghan G, Galligan M, Deady S, Gadallah B, Lenane P, Lally A, Houlihan DD, Morris PG, Sexton DJ, McCormick PA, Egan JJ, O'Neill JP, Conlon PJ, Moloney FJ.

Br J Dermatol. 2019 May 2. doi: 10.1111/bjd.18094. [Epub ahead of print]

PMID:
31049932
2.

The withdrawal of replacement therapy and outcomes in alpha-1 antitrypsin deficiency lung transplant recipients.

Kleinerova J, Ging P, Rutherford C, Lawrie I, Winward S, Eaton D, Redmond KC, Egan JJ.

Eur Respir J. 2019 May 18;53(5). pii: 1900055. doi: 10.1183/13993003.00055-2019. Print 2019 May. No abstract available.

PMID:
30819816
3.

Delivery of nucleic acids to ex vivo porcine airways using electrospray.

Riddell P, Gilbert JL, Molloy EL, Finnegan S, Egan JJ, O'Dea S.

Exp Lung Res. 2018 Oct - Nov;44(8-9):405-416. doi: 10.1080/01902148.2018.1563924. Epub 2019 Jan 24.

PMID:
30675820
4.

Near-fatal mucormycosis post-double lung transplant presenting as uncontrolled upper gastrointestinal haemorrhage.

O'Connor C, Farrell C, Fabre A, Eaton D, Redmond K, McSharry DG, Conneely JB, Shields CJ, Egan JJ, Hannan MM.

Med Mycol Case Rep. 2018 Mar 19;21:30-33. doi: 10.1016/j.mmcr.2018.03.009. eCollection 2018 Sep.

5.

Acute Respiratory Failure Post Single Lung Transplantation: An Unusual Cause.

Daly A, Egan JJ, Redmond KC.

Ir Med J. 2017 Oct 10;110(9):637.

PMID:
29372952
6.

The efficacy and safety of bronchial thermoplasty in severe persistent asthma on extended follow-up.

O'Reilly A, Browne I, Watchorn D, Egan JJ, Lane S.

QJM. 2018 Mar 1;111(3):155-159. doi: 10.1093/qjmed/hcx221.

PMID:
29149273
7.

Smoking-Related Interstitial Fibrosis: Evidence of Radiologic Regression with Advancing Age and Smoking Cessation.

Fabre A, Treacy A, Lavelle LP, Narski M, Faheem N, Healy D, Dodd JD, Keane MP, Egan JJ, Jebrak G, Mal H, Butler MW.

COPD. 2017 Dec;14(6):603-609. doi: 10.1080/15412555.2017.1378631. Epub 2017 Oct 18.

PMID:
29043847
8.

Renal transplantation outcomes following heart and heart-lung transplantation.

Wong L, Chee YR, Healy DG, Egan JJ, Sadlier DM, O'Meara YM.

Ir J Med Sci. 2017 Nov;186(4):1027-1032. doi: 10.1007/s11845-016-1550-3. Epub 2016 Dec 31.

PMID:
28040832
9.

Will ex-vivo lung perfusion allow a move towards daytime lung transplantation surgery?

Riddell P, Egan JJ.

Lancet Respir Med. 2017 Feb;5(2):88-89. doi: 10.1016/S2213-2600(16)30467-2. Epub 2016 Dec 22. No abstract available.

PMID:
28017342
10.

The Efficacy of Bronchial Thermoplasty for Severe Persistent Asthma: The First National Experience.

Watchorn DC, Sahadevan A, Egan JJ, Lane SJ.

Ir Med J. 2016 May 10;109(5):406.

PMID:
27685877
11.

International donor conversion rates for lung transplantation need to be standardised.

Riddell P, Egan JJ.

Lancet Respir Med. 2015 Dec;3(12):909-11. doi: 10.1016/S2213-2600(15)00462-2. No abstract available.

PMID:
26679015
12.

Successful surgical management of early esophageal cancer in a patient with cystic fibrosis post-bilateral lung transplantation.

Walsh SM, Maphango N, Egan JJ, Reynolds JV.

BMJ Case Rep. 2015 Nov 3;2015. pii: bcr2015210342. doi: 10.1136/bcr-2015-210342.

13.

Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction.

Raghu G, Nathan SD, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Wells AU, Shao L, Zhou H, Henig N, Szwarcberg J, Gillies H, Montgomery AB, O'Riordan TG.

Eur Respir J. 2015 Nov;46(5):1370-7. doi: 10.1183/13993003.01537-2014. Epub 2015 Aug 6.

14.

First bilateral lobar lung transplant in Ireland: advanced operative strategies in lung transplantation.

Shah AR, Healy DG, McCarthy JF, Egan JJ, Redmond K, Nolke L.

Ir Med J. 2014 Oct;107(9):290-1.

PMID:
25417390
15.

Anatomy and bronchoscopy of the porcine lung. A model for translational respiratory medicine.

Judge EP, Hughes JM, Egan JJ, Maguire M, Molloy EL, O'Dea S.

Am J Respir Cell Mol Biol. 2014 Sep;51(3):334-43. doi: 10.1165/rcmb.2013-0453TR. Review.

PMID:
24828366
16.

Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial.

Raghu G, Lynch D, Godwin JD, Webb R, Colby TV, Leslie KO, Behr J, Brown KK, Egan JJ, Flaherty KR, Martinez FJ, Wells AU, Shao L, Zhou H, Pedersen PS, Sood R, Montgomery AB, O'Riordan TG.

Lancet Respir Med. 2014 Apr;2(4):277-84. doi: 10.1016/S2213-2600(14)70011-6. Epub 2014 Feb 18.

PMID:
24717624
17.

Tunable vacuum ultraviolet laser based spectrometer for angle resolved photoemission spectroscopy.

Jiang R, Mou D, Wu Y, Huang L, McMillen CD, Kolis J, Giesber HG 3rd, Egan JJ, Kaminski A.

Rev Sci Instrum. 2014 Mar;85(3):033902. doi: 10.1063/1.4867517.

PMID:
24689595
18.

The burden of disease and the need for a simple staging system in idiopathic pulmonary fibrosis.

O'Connell OJ, Egan JJ.

Am J Respir Crit Care Med. 2014 Apr 1;189(7):765-7. doi: 10.1164/rccm.201402-0306ED. No abstract available.

PMID:
24684356
19.

Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events.

Costabel U, Bendstrup E, Cottin V, Dewint P, Egan JJ, Ferguson J, Groves R, Hellström PM, Kreuter M, Maher TM, Molina-Molina M, Nordlind K, Sarafidis A, Vancheri C.

Adv Ther. 2014 Apr;31(4):375-91. doi: 10.1007/s12325-014-0112-1. Epub 2014 Mar 18. Review. Erratum in: Adv Ther. 2014 May;31(5):575-6.

20.

Importance of idiopathic pulmonary fibrosis staging for clinical trial endpoints.

O'Connell OJ, Riddell P, Egan JJ.

Am J Respir Crit Care Med. 2013 Jun 1;187(11):1271. doi: 10.1164/rccm.201208-1555LE. No abstract available.

PMID:
23725620
21.

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.

Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, Lederer DJ, Shao L, Li X, Pedersen PS, Montgomery AB, Chien JW, O'Riordan TG; ARTEMIS-IPF Investigators*.

Ann Intern Med. 2013 May 7;158(9):641-9. doi: 10.7326/0003-4819-158-9-201305070-00003. Erratum in: Ann Intern Med. 2014 May 6;160(9):658.

PMID:
23648946
22.

The pathogenesis of pulmonary fibrosis: a moving target.

Wuyts WA, Agostini C, Antoniou KM, Bouros D, Chambers RC, Cottin V, Egan JJ, Lambrecht BN, Lories R, Parfrey H, Prasse A, Robalo-Cordeiro C, Verbeken E, Verschakelen JA, Wells AU, Verleden GM.

Eur Respir J. 2013 May;41(5):1207-18. doi: 10.1183/09031936.00073012. Epub 2012 Oct 25. Review.

23.

Emerging bronchoscopic therapies for stage IV advanced emphysema.

Egan JJ.

Chest. 2012 Sep;142(3):552-553. doi: 10.1378/chest.12-0596. No abstract available.

PMID:
22948571
24.

Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema.

Herth FJ, Ernst A, Baker KM, Egan JJ, Gotfried MH, Hopkins P, Stanzel F, Valipour A, Wagner M, Witt C, Kesten S, Snell G.

Int J Chron Obstruct Pulmon Dis. 2012;7:397-405. doi: 10.2147/COPD.S31082. Epub 2012 Jul 18.

25.

International collaboration: a retrospective study examining the survival of Irish citizens following lung transplantation in both the UK and Ireland.

Adamali HI, Judge EP, Healy D, Nolke L, Redmond KC, Bartosik W, McCarthy J, Egan JJ.

BMJ Open. 2012 Mar 28;2(2):e000605. doi: 10.1136/bmjopen-2011-000605. Print 2012.

26.

Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort.

Herth FJ, Noppen M, Valipour A, Leroy S, Vergnon JM, Ficker JH, Egan JJ, Gasparini S, Agusti C, Holmes-Higgin D, Ernst A; International VENT Study Group.

Eur Respir J. 2012 Jun;39(6):1334-42. doi: 10.1183/09031936.00161611. Epub 2012 Jan 26.

27.

Endobronchial valve deployment in severe α-1 antitrypsin deficiency emphysema: a case series.

Tuohy MM, Remund KF, Hilfiker R, Murphy DT, Murray JG, Egan JJ.

Clin Respir J. 2013 Jan;7(1):45-52. doi: 10.1111/j.1752-699X.2012.00280.x. Epub 2012 Apr 3.

PMID:
22236390
28.

Successful pregnancy outcome in a patient following heart, lung and renal transplant.

Dhonnchu TN, Regan C, Egan JJ.

Transpl Int. 2012 Mar;25(3):e43-4. doi: 10.1111/j.1432-2277.2011.01414.x. Epub 2012 Jan 3. No abstract available.

29.

Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Judge EP, Fabre A, Adamali HI, Egan JJ.

Eur Respir J. 2012 Jul;40(1):93-100. doi: 10.1183/09031936.00115511. Epub 2011 Dec 1.

30.

Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema.

Snell G, Herth FJ, Hopkins P, Baker KM, Witt C, Gotfried MH, Valipour A, Wagner M, Stanzel F, Egan JJ, Kesten S, Ernst A.

Eur Respir J. 2012 Jun;39(6):1326-33. doi: 10.1183/09031936.00092411. Epub 2011 Nov 10.

31.

Ganciclovir antiviral therapy in advanced idiopathic pulmonary fibrosis: an open pilot study.

Egan JJ, Adamali HI, Lok SS, Stewart JP, Woodcock AA.

Pulm Med. 2011;2011:240805. doi: 10.1155/2011/240805. Epub 2011 Apr 7.

32.

Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient.

Egan JJ.

Eur Respir Rev. 2011 Jun;20(120):114-7. doi: 10.1183/09059180.00001811. Review.

33.

The Novalung interventional lung assist as bridge to lung transplantation for self-ventilating patients - initial experience.

Bartosik W, Egan JJ, Wood AE.

Interact Cardiovasc Thorac Surg. 2011 Aug;13(2):198-200. doi: 10.1510/icvts.2011.266346. Epub 2011 May 4.

PMID:
21543364
34.

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis.

Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.

35.

Tailoring immunosuppressive therapy for lung transplantation: moving beyond hand-me-down data.

Chen H, Egan JJ.

Am J Respir Crit Care Med. 2011 Feb 1;183(3):290-1. doi: 10.1164/rccm.201009-1435ED. No abstract available.

PMID:
21288862
36.

Delayed diagnosis of novel H1N1 influenza pneumonitis in a vaccinated heart transplant recipient.

Judge EP, Hannan MM, McCarthy JF, Egan JJ.

J Heart Lung Transplant. 2011 Mar;30(3):357-8. doi: 10.1016/j.healun.2010.10.010. Epub 2010 Dec 18. No abstract available.

PMID:
21168347
37.

Neutrophil immunosurveillance for heart transplant rejection: a prospective study.

Healy DG, Watson RW, O'Mahony U, Egan JJ, Wood AE.

Transplant Proc. 2010 Jun;42(5):1788-92. doi: 10.1016/j.transproceed.2010.02.074.

PMID:
20620524
38.

An individualized representational intervention to improve symptom management (IRIS) in older breast cancer survivors: three pilot studies.

Heidrich SM, Brown RL, Egan JJ, Perez OA, Phelan CH, Yeom H, Ward SE.

Oncol Nurs Forum. 2009 May;36(3):E133-43. doi: 10.1188/09.ONF.E133-E143.

39.

CUX1/Wnt signaling regulates epithelial mesenchymal transition in EBV infected epithelial cells.

Malizia AP, Lacey N, Walls D, Egan JJ, Doran PP.

Exp Cell Res. 2009 Jul 1;315(11):1819-31. doi: 10.1016/j.yexcr.2009.04.001. Epub 2009 Apr 8.

PMID:
19361498
40.

A review of the lung transplantation programme in Ireland 2005-2007.

Bartosik W, Egan JJ, Soo A, Remund KF, Nölke L, McCarthy JF, Wood AE.

Eur J Cardiothorac Surg. 2009 May;35(5):807-11; discussion 811. doi: 10.1016/j.ejcts.2008.10.055. Epub 2009 Apr 5.

PMID:
19346136
41.

IL-4 increases CD21-dependent infection of pulmonary alveolar epithelial type II cells by EBV.

Malizia AP, Egan JJ, Doran PP.

Mol Immunol. 2009 May;46(8-9):1905-10. doi: 10.1016/j.molimm.2009.01.002. Epub 2009 Feb 4.

PMID:
19193442
42.

Infections relevant to lung transplantation.

Remund KF, Best M, Egan JJ.

Proc Am Thorac Soc. 2009 Jan 15;6(1):94-100. doi: 10.1513/pats.200809-113GO. Review.

PMID:
19131534
43.

Azithromycin attenuates effects of lipopolysaccharide on lung allograft bronchial epithelial cells.

Murphy DM, Forrest IA, Corris PA, Johnson GE, Small T, Jones D, Fisher AJ, Egan JJ, Cawston TE, Lordan JL, Ward C.

J Heart Lung Transplant. 2008 Nov;27(11):1210-6. doi: 10.1016/j.healun.2008.07.026. Epub 2008 Oct 1.

PMID:
18971093
44.

Lung tissue storage: optimizing conditions for future use in molecular research.

Keating DT, Malizia AP, Sadlier D, Hurson C, Wood AE, McCarthy J, Nolke L, Egan JJ, Doran PP.

Exp Lung Res. 2008 Oct;34(8):455-66. doi: 10.1080/01902140802093162.

PMID:
18850373
45.

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, Hirani N, Hubbard R, Lake F, Millar AB, Wallace WA, Wells AU, Whyte MK, Wilsher ML; British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee; Thoracic Society of Australia; New Zealand Thoracic Society; Irish Thoracic Society.

Thorax. 2008 Sep;63 Suppl 5:v1-58. doi: 10.1136/thx.2008.101691. No abstract available. Erratum in: Thorax. 2008 Nov;63(11):1029. multiple author names added.

PMID:
18757459
46.

Alveolar epithelial cell injury with Epstein-Barr virus upregulates TGFbeta1 expression.

Malizia AP, Keating DT, Smith SM, Walls D, Doran PP, Egan JJ.

Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L451-60. doi: 10.1152/ajplung.00376.2007. Epub 2008 Jul 11.

47.

Sirolimus for lymphangioleiomyomatosis lesions.

Egan JJ, Remund KF, Corris P.

N Engl J Med. 2008 May 1;358(18):1963-4; author reply 1964. doi: 10.1056/NEJMc086040. No abstract available.

PMID:
18450609
48.

Treatment of lobar atelectasis with bronchoscopically administered recombinant human deoxyribonuclease in cystic fibrosis?

McLaughlin AM, McGrath E, Barry R, Egan JJ, Gallagher CG.

Clin Respir J. 2008 Apr;2(2):123-6. doi: 10.1111/j.1752-699X.2007.00024.x.

PMID:
20298317
49.

Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients.

Murphy DM, Forrest IA, Corris PA, Johnson GE, Small T, Jones D, Fisher AJ, Egan JJ, Cawston TE, Ward C, Lordan JL.

Am J Physiol Lung Cell Mol Physiol. 2008 Mar;294(3):L592-9. doi: 10.1152/ajplung.00386.2007. Epub 2008 Jan 18.

50.

Host predisposition by endogenous Transforming Growth Factor-beta1 overexpression promotes pulmonary fibrosis following bleomycin injury.

Haider Y, Malizia AP, Keating DT, Birch M, Tomlinson A, Martin G, Ferguson MW, Doran PP, Egan JJ.

J Inflamm (Lond). 2007 Sep 20;4:18.

Supplemental Content

Support Center